We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-12.07%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.53B
AUM Growth
-$788M
Cap. Flow
+$56.7M
Cap. Flow %
1.03%
Top 10 Hldgs %
38.69%
Holding
757
New
85
Increased
147
Reduced
143
Closed
33

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$23.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$20.7M
3
HDB icon
HDFC Bank
HDB
+$17M
4
AMZN icon
Amazon
AMZN
+$14.4M
5
WEX icon
WEX
WEX
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 29.63%
2 Healthcare 18.25%
3 Financials 10.8%
4 Consumer Discretionary 9.75%
5 Consumer Staples 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
426
Range Resources
RRC
$9.28B
$45K ﹤0.01%
4,680
KHC icon
427
Kraft Heinz
KHC
$29.7B
$44K ﹤0.01%
1,026
+304
+42% +$15.7K
R icon
428
Ryder
R
$10.1B
$44K ﹤0.01%
+500
New +$28.7K
STEW
429
SRH Total Return Fund
STEW
$1.79B
$44K ﹤0.01%
+4,240
New +$45.1K
XYL icon
430
Xylem
XYL
$28.1B
$44K ﹤0.01%
661
BNY
431
Bank of New York Mellon
BNY
$110B
$42K ﹤0.01%
892
+92
+12% +$4.47K
OZK icon
432
Bank OZK
OZK
$5.74B
$42K ﹤0.01%
1,822
UNFI icon
433
United Natural Foods
UNFI
$2.89B
$42K ﹤0.01%
3,935
-765
-16% -$16.1K
APOG icon
434
Apogee Enterprises
APOG
$887M
$41K ﹤0.01%
+825
New +$29.6K
AGN
435
DELISTED
Allergan plc
AGN
$41K ﹤0.01%
310
-219
-41% -$35.9K
GS icon
436
Goldman Sachs
GS
$305B
$40K ﹤0.01%
242
+222
+1,110% +$44.8K
OCUL icon
437
Ocular Therapeutix
OCUL
$2.22B
$40K ﹤0.01%
+10,000
New +$55.1K
DAN icon
438
Dana Inc
DAN
$3.24B
$39K ﹤0.01%
+2,000
New +$30.3K
EWJ icon
439
iShares MSCI Japan ETF
EWJ
$23.2B
$39K ﹤0.01%
773
HSIC icon
440
Henry Schein
HSIC
$9.94B
$39K ﹤0.01%
638
-637
-50% -$41.9K
AZN icon
441
AstraZeneca
AZN
$245B
$38K ﹤0.01%
499
SRCL
442
DELISTED
Stericycle Inc
SRCL
$37K ﹤0.01%
1,000
+700
+233% +$32.9K
HII icon
443
Huntington Ingalls Industries
HII
$12.8B
$36K ﹤0.01%
190
WOLF icon
444
Wolfspeed
WOLF
$1.67B
$36K ﹤0.01%
840
A icon
445
Agilent Technologies
A
$42B
$35K ﹤0.01%
514
BWA icon
446
BorgWarner
BWA
$14B
$35K ﹤0.01%
1,136
JEF icon
447
Jefferies Financial Group
JEF
$12.7B
$35K ﹤0.01%
2,234
-28
-1% -$513
KBWB icon
448
Invesco KBW Bank ETF
KBWB
$6.84B
$35K ﹤0.01%
786
+36
+5% +$1.8K
VCSH icon
449
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$35K ﹤0.01%
+450
New +$35K
SIVB
450
DELISTED
SVB Financial Group
SIVB
$35K ﹤0.01%
+186
New +$45.5K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 757 positions worth $5.53B, down 12% from $6.31B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2018 filing shows 85 new, 147 increased, 143 reduced and 33 closed positions. Its largest new stake was UGI: 14,000 shares worth $747K. The largest sale was Celgene Corp, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2018 buy was UGI: 14,000 shares worth $747K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Salesforce in Q4 2018, an estimated $23.8M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $17.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Rockwell Collins in Q4 2018, selling an estimated $2.5M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 39% of its $5.53B portfolio in Q4 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 85 new positions and closed 33 in Q4 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 12% quarter-over-quarter to $5.53B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.